Clinical Trials · NCT06301191
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Attikon Hospital
- Enrollment
- 50
- Start date
- Mar 2022
- Locations
- 1 site, Greece
- Primary endpoint
- Comparison of arterial stiffness markers difference among treatment groups